Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The therapeutic reactivation of fetal haemoglobin Olivieri NF; Weatherall DJHum Mol Genet 1998[]; 7 (10): 1655-8Unusually high levels of fetal haemoglobin production can ameliorate sickle cell disease and beta thalassaemia. Although efforts directed at the pharmacological stimulation of fetal haemoglobin as an approach to managing these conditions have met with limited success, there is wide variation in individual responses. Whether this reflects the particular mutations that underlie these conditions or other genetic factors remains to be determined, as does the ideal combination of agents to achieve this end. These results are encouraging, however, in particular in view of the recent demonstration that other monogenic diseases, Duchenne muscular dystrophy, for example, might be amenable to the same therapeutic strategy.|Anemia, Sickle Cell/blood/genetics/*therapy[MESH]|Antisickling Agents/therapeutic use[MESH]|Butyrates/therapeutic use[MESH]|Clinical Trials as Topic[MESH]|Fetal Hemoglobin/*biosynthesis/genetics[MESH]|Humans[MESH]|Hydroxyurea/therapeutic use[MESH]|Up-Regulation/drug effects[MESH]|beta-Thalassemia/blood/genetics/*therapy[MESH] |